Stage IV Squamous Cell Lung Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB01248Docetaxel1 / 2Withdrawn1
DB11942Selinexor1 / 2Withdrawn1
DB12108Taselisib2Completed1
DB01248Docetaxel2 / 3Active Not Recruiting4
DB11714Durvalumab2 / 3Active Not Recruiting2
DB00530Erlotinib2 / 3Active Not Recruiting1
DB00530Erlotinib2 / 3Terminated1
DB06186Ipilimumab2 / 3Active Not Recruiting1
DB09035Nivolumab2 / 3Active Not Recruiting1
DB09073Palbociclib2 / 3Active Not Recruiting2
DB11972Rilotumumab2 / 3Active Not Recruiting1
DB11972Rilotumumab2 / 3Terminated1
DB11760Talazoparib2 / 3Active Not Recruiting1
DB12108Taselisib2 / 3Active Not Recruiting1
DB11771Tremelimumab2 / 3Active Not Recruiting1
DB00112Bevacizumab3Active Not Recruiting1
DB00958Carboplatin3Active Not Recruiting1
DB00002Cetuximab3Active Not Recruiting1
DB06186Ipilimumab3Active Not Recruiting1
DB06132Nivolumab3Active Not Recruiting1
DB09035Nivolumab3Active Not Recruiting1
DB01229Paclitaxel3Active Not Recruiting1